Unconfigured Ad

Collapse
This topic is closed.
X
X
 
  • Time
  • Show
Clear All
new posts
  • apfejes
    Senior Member
    • Feb 2008
    • 236

    #1

    Brief Introduction

    Well, alright, I should probably be working on a manuscript or two, or processing some sequences, but I'll take a quick shot at an introduction:

    I'm currently a graduate student at the BC Genome Sciences Centre, in Vancouver, BC, working towards a PhD in bioinformatics. My focus is on the use of Illumina/Solexa sequencing to identify mutations/pathways/genes involved in the development of cancers (primarily breast cancer). I've also been involved in several other projects, including transcriptome analysis, ChIP-Seq analysis and even a bit of aligner work.

    I currently have software developed in Java (cross-platform) to work on all of these different experiment types, and I'm slowly releasing them once they reach some semblance of maturity.

    I also blog on the topic of next-gen sequencing, on occasion, on my blog at fejes.ca.

    Cheers!

    Anthony
    The more you know, the more you know you don't know. —Aristotle

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2





    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification,...
    10-30-2026, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 07:59 AM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 11-05-2026, 09:25 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 11-03-2026, 11:54 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
169 views
0 reactions
Last Post SEQadmin2  
Working...